Last reviewed 2026-04-22 · How we verify

FURESTEM-AD Inj.

FURESTEM-AD is an allogeneic adipose tissue-derived mesenchymal stem cell product that modulates immune responses and promotes tissue repair in atopic dermatitis.

FURESTEM-AD is an allogeneic adipose tissue-derived mesenchymal stem cell product that modulates immune responses and promotes tissue repair in atopic dermatitis. Used for Atopic dermatitis.

At a glance

Mechanism of action

The drug consists of cultured mesenchymal stem cells derived from human adipose tissue that are administered via injection to affected skin areas. These cells are believed to work through immunomodulatory mechanisms, reducing inflammatory cytokine production and promoting anti-inflammatory responses, while also potentially enhancing tissue regeneration and barrier function in atopic dermatitis lesions.

Approved indications

• Atopic dermatitis

Common side effects

• Injection site reactions
• Infection risk
• Immune reactions

Key clinical trials

• Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis (PHASE1, PHASE2)
• Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (PHASE3)
• Evalution the Safety and Efficacy in Atopic Dermatitis Patients
• Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
• Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) (PHASE3)
• Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients
• Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
• Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.